Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma

Quan Wang(Capital Medical University), Chunhai Hao(Emory University)
PLoS ONE
August 22, 2013
Cited by 19


Related Papers